Top Markets
#1 Black Phoenix Black Phoenix +365.30%
#2 Islamic Coin Islamic Coin +158.16%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.04%
#5 Akedo Akedo +36.85%
#6 BasedHype BasedHype +32.76%
#7 Acurast Acurast +28.33%
#8 Cryptopia Cryptopia +21.42%
#9 Quantum Resistant Ledger Quantum Resistant Ledger +20.60%
#10 GoPlus Security GoPlus Security +19.08%
Coin of the day
Black Phoenix Black Phoenix
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Rang in Aktien #41146
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Aktienkurs
$0.04082105
Zuletzt synchronisiert: 2024-08-12
Marktkapitalisierung
$39.09K
Veränderung (1 Tag)
-19.83%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel Destiny Pharma plc (DEST)

Kategorie

Healthcare
P/S-Verhältnis für Destiny Pharma plc (DEST)
P/S-Verhältnis zum August 2026 TTM: 3.46
Laut den neuesten Finanzberichten und dem Aktienkurs von Destiny Pharma plc beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 3.46. Am Ende des Jahres 2022 lag das P/S-Verhältnis bei 243.09.
P/S-Verlauf für Destiny Pharma plc von 2013 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
2026 (TTM) 3.46 -95.47%
2023 76.33 -68.60%
2022 243.09 -47.78%
2021 465.54 -81.29%
2020 2.49K 3,941.09%
2019 61.58 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 185.98%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 198.20%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 44.11%
BE